In the News

The Series A funding came from a slew of investors, including Novartis, Philips, McKesson Ventures, ResMed, Providence Ventures and UPMC.

Xealth, a Seattle-based digital prescribing platform has raised $11 million in Series A funding from McKesson Ventures, Novartis, Philips, and ResMed. Existing investors Threshold Ventures (formerly DFJ Venture), Providence Ventures,…

Is there big market for prescriptions beyond drugs? Several investors with deep experience in health are betting on it — joining in a new $11 million funding round for Xealth,…

Xealth, the leading digital prescribing platform, today announced that it has raised $11 million in a Series A financing round, with new investment from health care industry leaders and investors…

True to their word, the company spun out in 2017. And today, Xealth announced an $11 million Series A to fuel further growth, with backing from a list of investors…

Xealth helps to bridge the existing drug and health care products supply chain with the digital, which opens up a new set of digitally-based treatment options that either stand alone…

The Froedtert & the Medical College of Wisconsin health network announced today they have teamed up with Proteus Digital Health and Xealth to provide an evidence-based Digital Medicines offering that…

You might have caught the publication of Built In Seattle's 50 Best Places to Work in 2019 a few weeks back and wondered, "How on Earth did they figure that…

ResMed is partnering with Providence St. Joseph to give clinicians insights into helping patients be more compliant, says ResMed's VP of SaaS Strategy Annie McBride.

Built In Seattle's Best Places to Work in Seattle list ranks the startups and tech companies with the best employee benefits and salary in 2019.